- Home
- BRX vs LNTH Comparison
BRX vs LNTH Comparison
Compare BRX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRX
- LNTH
- Stock Information
- Founded
- BRX 2011
- LNTH 1956
- Country
- BRX United States
- LNTH United States
- Employees
- BRX N/A
- LNTH N/A
- Industry
- BRX Real Estate Investment Trusts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BRX Real Estate
- LNTH Health Care
- Exchange
- BRX Nasdaq
- LNTH Nasdaq
- Market Cap
- BRX 8.7B
- LNTH 7.2B
- IPO Year
- BRX 2013
- LNTH 2015
- Fundamental
- Price
- BRX $29.79
- LNTH $88.09
- Analyst Decision
- BRX Buy
- LNTH Strong Buy
- Analyst Count
- BRX 13
- LNTH 7
- Target Price
- BRX $28.50
- LNTH $121.86
- AVG Volume (30 Days)
- BRX 2.1M
- LNTH 1.4M
- Earning Date
- BRX 10-28-2024
- LNTH 11-06-2024
- Dividend Yield
- BRX 3.89%
- LNTH N/A
- EPS Growth
- BRX N/A
- LNTH 304.57
- EPS
- BRX 1.08
- LNTH 6.02
- Revenue
- BRX $1,273,097,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- BRX N/A
- LNTH $19.56
- Revenue Next Year
- BRX $4.47
- LNTH $6.32
- P/E Ratio
- BRX $27.40
- LNTH $14.36
- Revenue Growth
- BRX 2.91
- LNTH 24.15
- 52 Week Low
- BRX $20.80
- LNTH $50.20
- 52 Week High
- BRX $29.70
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- BRX 69.12
- LNTH 39.89
- Support Level
- BRX $28.57
- LNTH $75.00
- Resistance Level
- BRX $29.72
- LNTH $118.21
- Average True Range (ATR)
- BRX 0.49
- LNTH 5.48
- MACD
- BRX 0.12
- LNTH -0.72
- Stochastic Oscillator
- BRX 94.92
- LNTH 26.37
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.